The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome

dc.contributor.authorSantos, Ana Celly Souza dos
dc.contributor.authorSoares, Nayara Pereira
dc.contributor.authorCosta, Eduardo Caldas
dc.contributor.authorSá, Joceline Cássia Ferrezini de
dc.contributor.authorAzevedo, George Dantas de
dc.contributor.authorLemos, Telma Maria Araújo Moura
dc.date.accessioned2021-02-23T18:35:18Z
dc.date.available2021-02-23T18:35:18Z
dc.date.issued2015-11-06
dc.description.resumoObjective: to evaluate inflammatory markers and insulin resistance (IR) in women with and without polycystic ovary syndrome (PCOS), with different body mass index (BMI). Methods: tumor necrosis factor-alpha (TNF-a), interleukin-6 (IL-6) and C-reactive protein (CRP) were assessed in serum samples from 40 women in reproductive age. Patients were divided into four groups: I (non-eutrophic with PCOS, n¼12), II (non-eutrophic without PCOS, n¼10), III (eutrophic with PCOS, n¼8) and IV (eutrophic without PCOS, n¼10) being non-eutrophic, the overweight and obese women with BMI425 kg/m2 and eutrophic women with BMI524.9 kg/m2. Homeostatic model assessment (HOMA-IR) was calculated for evaluation of IR. Results: PCOS patients showed increased levels of CRP (p50.01) and HOMA-IR (p50.01). When divided by BMI, both non-eutrophic and eutrophic PCOS showed increased CRP levels (p50.01) and HOMA-IR (p50.01). There were no differences in TNF-a and IL-6 levels between groups. Conclusion: in the PCOS group, the levels of CRP and IR were elevated, compared to their counterparts, regardless of body masspt_BR
dc.identifier.citationSANTOS, Ana Celly Souza dos; SOARES, Nayara Pereira; COSTA, Eduardo Caldas; SÁ, Joceline Cássia Ferrezini de; AZEVEDO, George Dantas de; LEMOS, Telma Maria Araújo Moura. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome. Gynecological Endocrinology, [s. l.], v. 31, n. 3, p. 225-228, 6 nov. 2015. Disponível em: https://www.tandfonline.com/doi/abs/10.3109/09513590.2014.976546?journalCode=igye20. Acesso em: 02 jul. 2020. http://dx.doi.org/10.3109/09513590.2014.976546pt_BR
dc.identifier.doi10.3109/09513590.2014.976546
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.urihttps://repositorio.ufrn.br/handle/123456789/31611
dc.languageenpt_BR
dc.publisherTaylor and Francispt_BR
dc.rightsAttribution 3.0 Brazil*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/br/*
dc.subjectCytokinespt_BR
dc.subjectInflammationpt_BR
dc.subjectInsulin resistancept_BR
dc.subjectNutritional statuspt_BR
dc.subjectObesitypt_BR
dc.subjectOvarypt_BR
dc.subjectPolycystic ovary syndromept_BR
dc.titleThe impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndromept_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
ImpactBodyMass_Azevedo_2015.pdf
Tamanho:
156.98 KB
Formato:
Adobe Portable Document Format
Carregando...
Imagem de Miniatura
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.45 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar